about
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for StrokeDiagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus GroupPhosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoidsEcstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermiaEnlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS).Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trialA circle-monitor for computerised assessment of visual neglect in peripersonal spaceThe Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesEffect of 3,4-methylenedioxyamphetamine on dendritic spine dynamics in rat neocortical neurons--involvement of heat shock protein 27.Robotic-assisted thymectomy: surgical procedure and results.Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase.Changes in chronotype after stroke: a pilot study.Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Influence of acute complications on outcome 3 months after ischemic stroke.Biomarkers and perfusion--training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial.Can a novel clinical risk score improve pneumonia prediction in acute stroke care? A UK multicenter cohort study.Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury.Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state.Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)Pathophysiology of stroke: lessons from animal models.Depletion of Cultivatable Gut Microbiota by Broad-Spectrum Antibiotic Pretreatment Worsens Outcome After Murine StrokeLipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic StrokeSocial work after stroke: identifying demand for support by recording stroke patients' and carers' needs in different phases after strokeCentral nervous system injury-induced immune deficiency syndrome.Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia.Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.The European LEMS Registry: Baseline Demographics and Treatment ApproachesAdult hemophagocytic lymphohistiocytosis causing multi organ dysfunction in a patient with multiple autoimmune disorders: when the immune system runs amok.Stroke-induced immunodepression: experimental evidence and clinical relevance.Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach.Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?Epigenetic mechanisms in cerebral ischemia.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS).Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion levelFatigue in myasthenia gravis: risk factors and impact on quality of life.Sugar for the brain: the role of glucose in physiological and pathological brain function
P50
Q28069455-F7ECE4AE-15B6-4E6E-A12C-184708991BABQ28085110-86F38964-EFDF-4AC3-BD9B-46F1AE02023FQ28569805-82857D60-C851-48F4-8D87-845121C63F8BQ28578628-65F60A43-2EC5-4C1A-AE58-421E56A6B8B8Q30734308-540EB8C3-94C5-40A7-99E5-D98EFFEE1E59Q33334457-D14B9FA7-95F7-495A-942D-F3E849E907E8Q33357381-9D03937F-ACD6-48E6-979D-76583BD6A413Q33594399-BD0C4203-25E0-43BD-99F4-0DC6FE069FC6Q33660088-766AC940-AD52-4E2F-9649-1B5DF86C433FQ33746094-3D0392CB-CE4D-454F-B90E-02806122AFEFQ34043549-C0951193-7F5C-47F0-8557-616568F83AEDQ34314471-C8CC71AB-6A60-4929-BA37-2CA25DFC3880Q34380700-1BC83F75-F072-4ED1-A4D4-EDAD8FACF6EFQ34913109-5995684B-DA7C-4539-898A-6E47BCBF64EDQ34976260-1B79212D-B5FE-4475-AE2A-E7505F86C8FAQ35005924-486EAB24-809B-45A0-90E1-D10786521410Q35065455-448A7E95-824A-4A0D-875B-16D976466462Q35088088-8FCC4F4A-D016-4F60-A459-802DDD98DD28Q35153024-19A9D57E-45A0-48E3-A863-85B298EA8883Q35749617-60427B01-80C7-46B9-834D-5344828C8718Q35877852-97F0DA37-41A0-4241-81DE-EC75831DA73BQ35899914-7270DF85-0DE7-4852-9C51-96AB48C0175FQ35956294-FCE3F145-8EEC-40BF-A086-E0F731F7F09CQ35983314-97765CFA-4953-43AE-ADFB-B0FF0A3C0131Q36010841-6320BC71-D1C0-4124-BF09-F125A5DE2100Q36083245-8FCA7F5D-AEC0-4E87-9000-47C74C56BB98Q36257627-502E6424-E70A-4B56-A039-DA31B130E7F1Q36267373-43D6DE46-A4CD-4088-8121-04FF24B85355Q36371682-36596FA1-7811-4E00-8B73-49F4EAA6E987Q36389693-CE548494-FE7B-4B37-810E-41041CFFBF6AQ36530710-E30E02A6-2E3B-4DF5-BC25-18B0DD6D45BEQ36721677-D10F4968-30E2-4A59-AD36-1CC018F301FEQ36914619-E304A7FF-91E6-4F17-8E31-2F8879A7E374Q37134802-3E5EF004-58E2-4CE0-956E-D4783133E374Q37150340-DAEC25B4-4B8C-4D0F-854E-772FE8FB9669Q37158226-8E631540-BC99-4300-8928-8EDF9B1F9F9EQ37176492-775A07BA-91C0-4FAE-A3A7-757E36F7B542Q37238155-D8004F95-F6AA-468D-BC93-BDE0FA3F8DEEQ37339784-FE99F0C4-3340-4F00-9940-D0C56B7150B0Q37511476-82C4E0F4-7F95-4123-A890-D6304806CC9C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Meisel
@ast
Andreas Meisel
@en
Andreas Meisel
@es
Andreas Meisel
@nl
type
label
Andreas Meisel
@ast
Andreas Meisel
@en
Andreas Meisel
@es
Andreas Meisel
@nl
prefLabel
Andreas Meisel
@ast
Andreas Meisel
@en
Andreas Meisel
@es
Andreas Meisel
@nl
P214
P106
P1153
57205511020
7006436032
P21
P214
P2798
P31
P496
0000-0001-7233-5342
P735
P7859
lccn-n96011269